The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...
China is expected to witness the highest prevalence with an estimated 10.4 million cases. The total prevalent cases of ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
Alzheimer’s disease is the most common cause of dementia in older adults. But according to experts, the condition affects men ...
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...
I've seen firsthand how people sharing their stories is very therapeutic and allows other people to open up themselves,” Seth ...
The balance of protein health within cells, a process known as proteostasis, is critical for maintaining cellular ...
Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...